HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 76 filers reported holding HARVARD BIOSCIENCE INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $1,430,000 | +33.0% | 252,290 | -4.0% | 0.13% | +53.6% |
Q3 2014 | $1,075,000 | -7.6% | 262,915 | +2.9% | 0.08% | +1.2% |
Q2 2014 | $1,163,000 | +9.6% | 255,615 | +14.2% | 0.08% | +13.7% |
Q1 2014 | $1,061,000 | +1.3% | 223,890 | +0.5% | 0.07% | -11.0% |
Q4 2013 | $1,047,000 | +68.3% | 222,795 | +88.4% | 0.08% | +64.0% |
Q3 2013 | $622,000 | – | 118,265 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Harvey Partners, LLC | 790,000 | $2,378,000 | 3.09% |
Alambic Investment Management, L.P. | 25,398 | $76,000 | 0.83% |
Adirondack Research & Management Inc. | 190,494 | $573,000 | 0.80% |
Archon Capital Management LLC | 881,794 | $2,654,000 | 0.53% |
BARD ASSOCIATES INC | 1,483,610 | $4,465,000 | 0.47% |
DALTON GREINER HARTMAN MAHER & CO | 909,977 | $2,739,000 | 0.45% |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,537,800 | $4,629,000 | 0.40% |
Portolan Capital Management | 979,067 | $2,947,000 | 0.33% |
HEARTLAND ADVISORS INC | 961,400 | $2,894,000 | 0.25% |
Granahan Investment Management | 1,757,176 | $5,289,000 | 0.18% |